Dual Vaccine Strategy Targets Genital Herpes Prevention
Yale researchers have developed a 'prime and pull' vaccine strategy that shows promise in preventing genital herpes in preclinical models. The method uses an initial injection to prime the immune system, followed by a localized nanoparticle treatment to target the infection site.
Why it matters
This represents a potential breakthrough in treating a lifelong infection that currently lacks a cure or preventative vaccine.
Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or prevent transmission. Now, Yale School of Medicine researchers have taken a significant step toward a genital herpes vaccine that in preclinical models prevented infection.
The article is a straightforward report on scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in